share_log

Assure | S-4: Registration of securities issued in business combination transactions

Assure | S-4: Registration of securities issued in business combination transactions

Assure | S-4:企业合并证券发行登记
美股sec公告 ·  05/03 12:42
Moomoo AI 已提取核心信息
Assure Holdings Corp. has announced a pending merger with Danam Health, Inc., which will result in Danam Health merging with Assure's subsidiary, Merger Sub, and subsequently becoming a wholly-owned subsidiary of Assure. The post-merger entity will be renamed Danam Health Holding Corporation. The merger is contingent upon shareholder approval and the satisfaction of certain conditions, including regulatory clearances and the absence of material adverse effects. Assure's board has unanimously recommended that shareholders vote in favor of the merger, which will be decided at a Special Meeting to be held virtually in 2024, with the exact date yet to be determined. Shareholders will receive voting instructions and Advantage Proxy has been engaged to assist with proxy solicitation. Additionally...Show More
Assure Holdings Corp. has announced a pending merger with Danam Health, Inc., which will result in Danam Health merging with Assure's subsidiary, Merger Sub, and subsequently becoming a wholly-owned subsidiary of Assure. The post-merger entity will be renamed Danam Health Holding Corporation. The merger is contingent upon shareholder approval and the satisfaction of certain conditions, including regulatory clearances and the absence of material adverse effects. Assure's board has unanimously recommended that shareholders vote in favor of the merger, which will be decided at a Special Meeting to be held virtually in 2024, with the exact date yet to be determined. Shareholders will receive voting instructions and Advantage Proxy has been engaged to assist with proxy solicitation. Additionally, Danam shareholders have appraisal rights under Delaware law. Assure has also entered into a Partial Waiver and Amendment Agreement with Danam, issuing a $1 million unsecured convertible note as consideration for the Waiver Agreement. The merger's completion is also subject to the approval of Nasdaq for the listing of New Danam’s common stock. If the merger agreement is terminated under specified conditions, Assure may be required to pay Danam a termination fee. Upon successful completion of the merger, Assure’s public shareholders will hold approximately 10% of New Danam, with the remaining 90% owned by Danam shareholders.
Assure Holdings Corp. 宣布即将与达南健康公司进行合并,这将导致达南健康与Assure的子公司Merger Sub合并,随后成为Assure的全资子公司。合并后的实体将更名为达南健康控股公司。合并取决于股东的批准和某些条件的满足,包括监管许可和不产生重大不利影响。Assure董事会一致建议股东对合并投赞成票,合并将在2024年虚拟举行的特别会议上决定,确切日期尚未确定。股东将收到投票指示,并且已聘请Advantage Proxy协助代理招标。此外,根据特拉华州法律,达南股东拥有评估权。Assure还与Danam签订了部分豁免和修正协议,发行了100万美元的无抵押可转换票据作为豁免协议的对价。合并的完成还需要纳斯达克批准新达南普通股的上市。如果合并协议在特定条件下终止,则Assure可能需要向Danam支付终止费。合并成功完成后,Assure的公众股东将持有新达南约10%的股份,其余90%由达南股东持有。
Assure Holdings Corp. 宣布即将与达南健康公司进行合并,这将导致达南健康与Assure的子公司Merger Sub合并,随后成为Assure的全资子公司。合并后的实体将更名为达南健康控股公司。合并取决于股东的批准和某些条件的满足,包括监管许可和不产生重大不利影响。Assure董事会一致建议股东对合并投赞成票,合并将在2024年虚拟举行的特别会议上决定,确切日期尚未确定。股东将收到投票指示,并且已聘请Advantage Proxy协助代理招标。此外,根据特拉华州法律,达南股东拥有评估权。Assure还与Danam签订了部分豁免和修正协议,发行了100万美元的无抵押可转换票据作为豁免协议的对价。合并的完成还需要纳斯达克批准新达南普通股的上市。如果合并协议在特定条件下终止,则Assure可能需要向Danam支付终止费。合并成功完成后,Assure的公众股东将持有新达南约10%的股份,其余90%由达南股东持有。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息